DCAF17: A Potential Drug Target and Biomarker (G80067)

Target Name: DCAF17

NCBI ID: G80067

DCAF17

DCAF17: A Potential Drug Target and Biomarker

DCAF17 (C2orf37) is a protein that is expressed in various tissues throughout the body. It is a member of the C2 subfamily of theufibroblast growth factor receptor family and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. The protein is also known as CDK4-SPG2, and it is a potential drug target and biomarker for various diseases.

The DCAF17 gene

DCAF17 is a member of the Pax gene family, which is responsible for the regulation of cellular processes such as cell growth, differentiation, and survival. The Pax gene family is characterized by the presence of a specific domain, known as the Pax domain, which is responsible for the regulation of gene expression.

The DCAF17 protein

DCAF17 is a 21-kDa protein that is expressed in various tissues throughout the body. It is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. DCAF17 is a member of the C2 subfamily of theufibroblast growth factor receptor family, which is characterized by the presence of a specific domain, known as the Pax domain, that is responsible for the regulation of gene expression.

The DCAF17 gene

The DCAF17 gene is located on chromosome 18q21 and encodes a protein of 21 kDa. The protein is made up of 155 amino acid residues and has a calculated pI of 1.95. DCAF17 is expressed in various tissues throughout the body, including the liver, lung, heart, and muscle.

DCAF17 as a drug target

DCAF17 is a potential drug target for various diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cellular processes that are associated with the development and progression of many diseases. For example, DCAF17 is involved in the regulation of cell growth, which is a key factor in the development of cancer. In addition, DCAF17 is involved in the regulation of cell differentiation, which is a key factor in the development of neural tube defects such as Down syndrome.

DCAF17 as a biomarker

DCAF17 is also a potential biomarker for various diseases. Its involvement in the regulation of cellular processes makes it an attractive target for diagnostic tests. For example, DCAF17 has been used as a biomarker for the diagnosis of pancreatic cancer. In addition, DCAF17 has been used as a biomarker for the diagnosis of neuroblastoma, a type of cancer that affects the nervous system.

Conclusion

DCAF17 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. Its potential as a drug target and biomarker for various diseases makes it an attractive target for research and development. Further studies are needed to fully understand the role of DCAF17 in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: DDB1 And CUL4 Associated Factor 17

Functions: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex

The "DCAF17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DCAF17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets